Avoid common mistakes on your manuscript.
The authors would like to thank Dr. Kalmar for his interest in our work, and we agree with his assessments: pollution with the Memsorb system as tested is clearly excessive, and this is further supported by the data presented by Dr. Kalmar. The purpose of our study was more a proof of concept, as stated in the manuscript: “…it is clear that the current technology is feasible but by no means ready for widespread clinical use”. Memsorb is a technology under development, and improvements in membrane properties are clearly warranted. We also suggested that the environmental impact of inhaled anesthetics should be further reduced by combining the Memsorb with anesthetic agent scavenging and/or recycling technology or technology that decomposes waste gas into harmless, environmentally safe components. Life cycle analyses will define Memsorb’s future role, and we thank Dr. Kalmar for emphasizing this.
Sarah Eerlings
Jan F.A. Hendrickx
Andre M. De Wolf
Funding
Jan Hendrickx has received lecture support, travel reimbursements, equipment loans, consulting fees and/or meeting organizational support from a number of companies involved with inhaled agent delivery (alphabetically): AbbVie, Acertys, Air Liquide, Allied Healthcare, Armstrong Medical, Baxter, Dräger, GE, Hospithera, Heinen und Löwenstein, Intersurgical, Maquet, MDMS, MEDEC, Micropore, Molecular, NWS, Philips, Quantum Medical. None of the authors has been involved with the development of the Memsorb or financially rewarded in any way by DMF Medical, Halifax, Canada.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The other authors declare that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Eerlings, S.A., De Wolf, A.M. & Hendrickx, J.F.A. Reply to: Life cycle assessment of memsorb use. J Clin Monit Comput 36, 1573 (2022). https://doi.org/10.1007/s10877-022-00847-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10877-022-00847-9